191 related articles for article (PubMed ID: 17546492)
1. Role of a consensus AP-2 regulatory sequence within the Epstein-Barr virus LMP1 promoter in EBNA2 mediated transactivation.
Jansson A; Johansson P; Yang W; Palmqvist L; Sjöblom-Hallén A; Rymo L
Virus Genes; 2007 Oct; 35(2):203-14. PubMed ID: 17546492
[TBL] [Abstract][Full Text] [Related]
2. PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter.
Sjöblom A; Jansson A; Yang W; Laín S; Nilsson T; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2679-92. PubMed ID: 7595375
[TBL] [Abstract][Full Text] [Related]
3. An ATF/CRE element mediates both EBNA2-dependent and EBNA2-independent activation of the Epstein-Barr virus LMP1 gene promoter.
Sjöblom A; Yang W; Palmqvist L; Jansson A; Rymo L
J Virol; 1998 Feb; 72(2):1365-76. PubMed ID: 9445037
[TBL] [Abstract][Full Text] [Related]
4. Silencing of the Epstein-Barr virus latent membrane protein 1 gene by the Max-Mad1-mSin3A modulator of chromatin structure.
Sjöblom-Hallén A; Yang W; Jansson A; Rymo L
J Virol; 1999 Apr; 73(4):2983-93. PubMed ID: 10074148
[TBL] [Abstract][Full Text] [Related]
5. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
6. Interferon regulatory factor 7 regulates expression of Epstein-Barr virus latent membrane protein 1: a regulatory circuit.
Ning S; Hahn AM; Huye LE; Pagano JS
J Virol; 2003 Sep; 77(17):9359-68. PubMed ID: 12915551
[TBL] [Abstract][Full Text] [Related]
7. The NP9 protein encoded by the human endogenous retrovirus HERV-K(HML-2) negatively regulates gene activation of the Epstein-Barr virus nuclear antigen 2 (EBNA2).
Gross H; Barth S; Pfuhl T; Willnecker V; Spurk A; Gurtsevitch V; Sauter M; Hu B; Noessner E; Mueller-Lantzsch N; Kremmer E; Grässer FA
Int J Cancer; 2011 Sep; 129(5):1105-15. PubMed ID: 21710493
[TBL] [Abstract][Full Text] [Related]
8. Counteracting effects of cellular Notch and Epstein-Barr virus EBNA2: implications for stromal effects on virus-host interactions.
Rowe M; Raithatha S; Shannon-Lowe C
J Virol; 2014 Oct; 88(20):12065-76. PubMed ID: 25122803
[TBL] [Abstract][Full Text] [Related]
9. Activity of the LMP1 gene promoter in Epstein-Barr virus-transformed cell lines is modulated by sequence variations in the promoter-proximal CRE site.
Jansson A; Johansson P; Li S; Rymo L
J Gen Virol; 2007 Jul; 88(Pt 7):1887-1894. PubMed ID: 17554019
[TBL] [Abstract][Full Text] [Related]
10. Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell Factor.
Murata T; Noda C; Narita Y; Watanabe T; Yoshida M; Ashio K; Sato Y; Goshima F; Kanda T; Yoshiyama H; Tsurumi T; Kimura H
J Virol; 2016 Apr; 90(8):3873-3889. PubMed ID: 26819314
[TBL] [Abstract][Full Text] [Related]
11. Functional cooperation of Epstein-Barr virus nuclear antigen 2 and the survival motor neuron protein in transactivation of the viral LMP1 promoter.
Voss MD; Hille A; Barth S; Spurk A; Hennrich F; Holzer D; Mueller-Lantzsch N; Kremmer E; Grässer FA
J Virol; 2001 Dec; 75(23):11781-90. PubMed ID: 11689659
[TBL] [Abstract][Full Text] [Related]
12. Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus.
Chau CM; Lieberman PM
J Virol; 2004 Nov; 78(22):12308-19. PubMed ID: 15507618
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of an Epstein-Barr virus nuclear antigen 2-responsive cis element in the bidirectional promoter region of latent membrane protein and terminal protein 2 genes.
Laux G; Dugrillon F; Eckert C; Adam B; Zimber-Strobl U; Bornkamm GW
J Virol; 1994 Nov; 68(11):6947-58. PubMed ID: 7933076
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter.
Wang L; Grossman SR; Kieff E
Proc Natl Acad Sci U S A; 2000 Jan; 97(1):430-5. PubMed ID: 10618435
[TBL] [Abstract][Full Text] [Related]
15. Cell phenotype-dependent control of Epstein-Barr virus latent membrane protein 1 gene regulatory sequences.
Fåhraeus R; Jansson A; Sjöblom A; Nilsson T; Klein G; Rymo L
Virology; 1993 Jul; 195(1):71-80. PubMed ID: 8391188
[TBL] [Abstract][Full Text] [Related]
16. Hyperphosphorylation of EBNA2 by Epstein-Barr virus protein kinase suppresses transactivation of the LMP1 promoter.
Yue W; Gershburg E; Pagano JS
J Virol; 2005 May; 79(9):5880-5. PubMed ID: 15827205
[TBL] [Abstract][Full Text] [Related]
17. Response to cAMP levels of the Epstein-Barr virus EBNA2-inducible LMP1 oncogene and EBNA2 inhibition of a PP1-like activity.
Fåhraeus R; Palmqvist L; Nerdstedt A; Farzad S; Rymo L; Laín S
EMBO J; 1994 Dec; 13(24):6041-51. PubMed ID: 7813442
[TBL] [Abstract][Full Text] [Related]
18. The LMP1 promoter can be transactivated directly by NF-kappaB.
Demetriades C; Mosialos G
J Virol; 2009 May; 83(10):5269-77. PubMed ID: 19279104
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the Epstein-Barr virus C promoter by AUF1 and the cyclic AMP/protein kinase A signaling pathway.
Fuentes-Pananá EM; Peng R; Brewer G; Tan J; Ling PD
J Virol; 2000 Sep; 74(17):8166-75. PubMed ID: 10933728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
